EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid-based Nanoparticles: Strategy for Targeted Cancer Therapy

Ashish Singh Chauhan, Pallavi Chand, Tarun Parashar

BIO Integration · 2025 · 6 (1)

DOI: 10.15212/bioi-2024-0107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIO Integration, 2025. Verfasst von Ashish Singh Chauhan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid-based Nanoparticles (LBNPs) have emerged as a transformative approach in cancer treatment, offering innovative drug delivery solutions that enhance therapeutic efficacy while minimizing adverse effects. By exploring the characterization, classification, synthesis, targeting strategies, and advantages of LBNPs, this study highlights how LBNPs have been used to overcome the limitations of traditional chemotherapy and improve patient outcomes. As nanotechnology revolutionizes cancer therapy, the emergence of LBNPs as a promising strategy for targeted drug delivery has led to optimism regarding the future of cancer treatment. This review extensively assesses the structure, categories, production methods, targeting strategies, benefits, and recent advancements in LBNPs for treating cancer. It also highlights current challenges and possible future directions. This review is aimed at providing a comprehensive understanding of LBNPs’ potential in cancer therapy. Liposomes, nanostructured lipid carriers, solid lipid nanoparticles, and lipid-polymer hybrid nanoparticles are all types of LBNPs, each with unique features of interest for cancer therapy. These particles can be synthesized through various procedures, such as bulk nanoprecipitation, solvent-based emulsification, or microfluidics. Passive targeting systems, active targeting systems, and responsive delivery platforms direct LBNPs to tumors. Consequently, LBNPs provide an improved drug release pattern that minimizes side effects while enhancing therapeutic efficacy. With the potential for combination therapy, LBNPs offer a hopeful future for cancer treatment. Continued research is expected to improve patient outcomes and overall quality of life in cancer care.

Zitieren

APA

Chauhan, A. S., Chand, P., & Parashar, T. (2025). Lipid-based Nanoparticles: Strategy for Targeted Cancer Therapy. BIO Integration, 6(1). https://doi.org/10.15212/bioi-2024-0107

Vancouver

Chauhan AS, Chand P, Parashar T. Lipid-based Nanoparticles: Strategy for Targeted Cancer Therapy. BIO Integration. 2025;6(1). doi:10.15212/bioi-2024-0107

BibTeX
@article{Chauhan2025,
  author = {Chauhan, Ashish Singh and Chand, Pallavi and Parashar, Tarun},
  title = {Lipid-based Nanoparticles: Strategy for Targeted Cancer Therapy},
  journal = {BIO Integration},
  year = {2025},
  volume = {6},
  number = {1},
  doi = {10.15212/bioi-2024-0107}
}
Kostenlos starten →